Zaroxolyn en es it fr

Zaroxolyn Brand names, Zaroxolyn Analogs

Zaroxolyn Brand Names Mixture

  • No information avaliable

Zaroxolyn Chemical_Formula

C18H14Cl4N2O

Zaroxolyn RX_link

http://www.rxlist.com/cgi/generic2/micon.htm

Zaroxolyn fda sheet

Zaroxolyn FDA

Zaroxolyn msds (material safety sheet)

Zaroxolyn MSDS

Zaroxolyn Synthesis Reference

No information avaliable

Zaroxolyn Molecular Weight

416.127 g/mol

Zaroxolyn Melting Point

159 - 163 oC

Zaroxolyn H2O Solubility

1g/100mL (20°C)

Zaroxolyn State

Solid

Zaroxolyn LogP

6.02

Zaroxolyn Dosage Forms

Topical cream (2%); Vaginal cream (2%); Vaginal suppositories (100mg, 200mg)

Zaroxolyn Indication

For topical application in the treatment of tinea pedis (athlete’s foot), tinea cruris, and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, in the treatment of cutaneous candidiasis (moniliasis), and in the treatment of tinea versicolor.

Zaroxolyn Pharmacology

Miconazole is an anti-fungal medication related to fluconazole (Diflucan), ketoconazole (Nizoral), itraconazole (Sporanox), and clotrimazole (Lotrimin, Mycelex). It is used either on the skin or in the vagina for fungal infections. Miconazole was approved by the FDA in 1974. Miconazole prevents fungal organisms from producing vital substances required for growth and function. This medication is effective only for infections caused by fungal organisms. It will not work for bacterial or viral infections.

Zaroxolyn Absorption

No information avaliable

Zaroxolyn side effects and Toxicity

Oral, mouse: LD50 = 3800 mg/kg; Oral, rat: LD50 = 3 gm/kg. Ingestion of the amounts of the components contained in a tube of cream are unlikely to produce overdosage and toxic effects.

Zaroxolyn Patient Information

No information avaliable

Zaroxolyn Organisms Affected

Fungi, yeast and protozoans